Patent · US Expired

Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules

US6458758B1 · kind B1 · utility

14Cited by
3References
2Claims
0Family size

Assignee

Inventor

Key dates

Filing dateMar 26, 1997
Grant dateOct 1, 2002
Priority date
Expiry dateMar 26, 2017

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions and processes to alleviate free radical toxicity are disclosed based on the use of nitroxides in association with physiologically compatible macromolecules. In particular, hemoglobin-based red cell substitutes are described featuring stable nitroxide free radicals for use in cell-free hemoglobin solutions, encapsulated hemoglobin solutions, stabilized hemoglobin solutions, polymerized hemoglobin solutions, conjugated hemoglobin solutions, nitroxide-labelled albumin, and nitroxide-labelled immunoglobulin. Formulations are described herein that interact with free radicals, acting as antioxidant enzyme-mimics, which preserve nitroxides in their active form in vivo. Applications are described including blood substitutes, radioprotective agents, imaging agents, agents to protect against ischemia and reperfusion injury, particularly in cerebral ischemia in stroke, and in vivo enzyme mimics among others.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.